x

Search for an orphan drug

* (*) mandatory field

Other search option(s)

Marketing authorization with orphan designation - USA

  • Tradename: MYLOTARG
  • ATC code : -
  • EU Number: -
  • MA date : 01/09/2017
  • MA holder: WYETH PHARMACEUTICALS INC.

Therapeutic indication

- Treatment of newly-diagnosed CD33-positive acute myeloid leukemia in adults.
- Treatment of relapsed or refractory CD33-positive acute myeloid leukemia in adults and in pediatric patients 2 years and older.

Diseases list

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.